Antitumor ether lipids: endocytosis as a determinant of cellular sensitivity.
Workman
P
P
CRC Department of Medical Oncology, University of Glasgow, Scotland, UK.
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D004351:Drug Resistance; D004705:Endocytosis; D005663:Furans / Q000494:pharmacology*; D006801:Humans; D009857:Oncogenes; D010742:Phospholipid Ethers / Q000494:pharmacology*; D010980:Platelet Membrane Glycoproteins; D011956:Receptors, Cell Surface / Q000502:physiology; D043562:Receptors, G-Protein-Coupled
D000970:Antineoplastic Agents; D005663:Furans; D010742:Phospholipid Ethers; D010980:Platelet Membrane Glycoproteins; D011956:Receptors, Cell Surface; D043562:Receptors, G-Protein-Coupled; C039351:platelet activating factor receptor; C055462:SRI 62-834; C026659:edelfosine